The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Abstract
Initial description of apolipoprotein (apo) E-deficient transgenic mice demonstrated the development of severe hypercholesterolemia due to probable delayed clearance of large atherogenic particles from the circulation. Examination of these mice demonstrated foam cell accumulation in the aortic root and pulmonary arteries by 10 weeks of age. In the present study, the animals were fed either chow or a high-fat, Western-type diet and examined at ages ranging from 6 to 40 weeks. Gross examination by dissection microscopy revealed a predilection for development of lesions in the aortic root, at the lesser curvature of the aortic arch, the principal branches of the aorta, and in the pulmonary and carotid arteries. Monocyte attachment to endothelial cells was observed by light and electron microscopic examination at 6 weeks, the earliest time point examined. Foam cell lesions developed as early as 8 weeks, and after 15 weeks advanced lesions (fibrous plaques) were observed. The latter consisted of a fibrous cap containing smooth muscle cells surrounded by connective tissue matrix that covered a necrotic core with numerous foamy macrophages. Mice fed the Western-type diet generally had more advanced lesions than those fed a chow diet. The apoE-deficient mouse contains the entire spectrum of lesions observed during atherogenesis and is the first mouse model to develop lesions similar to those in humans. This model should provide numerous opportunities to study the pathogenesis and therapy of atherosclerosis in a small, genetically defined animal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Apo E knockout mice are considered to be one of the most relevant models for atherosclerosis because they are hypercholesterolemic and develop spontaneous arterial lesions (87).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [87]
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Self-citationPlump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Self-citationSpontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Rg, G. (1981) · PubMed Central · Cited by 1,314
Faggiotto, A., Ross, R., & Harker, L. A. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.4.323 · Cited by 978
Self-citationGown, A. M., Tsukada, T., & Ross, R. (1986) · PubMed · Cited by 678
Self-citationFaggiotto, A., & Ross, R. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.4.341 · Cited by 466
Self-citationThe role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions.
Gerrity, R. G. (1981) · PubMed · Cited by 459
Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein
Marotti, K. R., Castle, C. K., Boyle, T. P., Lin, A. H., Murray, R. W., & Melchior, G. W. (1993) · Nature · doi:10.1038/364073a0 · Cited by 444
Atherosclerosis in Transgenic Mice Overexpressing Apolipoprotein A-II
Warden, C. H., Hedrick, C. C., Qiao, J.-H., Castellani, L. W., & Lusis, A. J. (1993) · Science · doi:10.1126/science.8332912 · Cited by 359
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Plasma proteomic profiles of bovine growth hormone transgenic mice as they age
Ding, J., Berryman, D. E., & Kopchick, J. J. (2011) · Transgenic Research · doi:10.1007/s11248-011-9499-5 · Cited by 27
Intervertebral disc degeneration and ectopic bone formation in apolipoprotein E knockout mice
Zhang, D., Jin, L., Reames, D. L., Shen, F. H., Shimer, A. L., & Li, X. J. (2012) · Journal of Orthopaedic Research® · doi:10.1002/jor.22216 · Cited by 26
Leo, G. C., & Darrow, A. L. (2009) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.2470 · Cited by 26
Development of a quantitative mechanical test of atherosclerotic plaque stability
Wang, Y., Ning, J., Johnson, J. A., Sutton, M. A., & Lessner, S. M. (2011) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2011.06.026 · Cited by 26
Schroeter, M. R., Humboldt, T., Schäfer, K., & Konstantinides, S. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.11.013 · Cited by 26
Zhaorigetu, S., Rodriguez‐Aguayo, C., Sood, A. K., Lopez‐Berestein, G., & Walton, B. L. (2014) · Journal of Liposome Research · doi:10.3109/08982104.2013.863208 · Cited by 26
Han, H., Qiu, F., Zhao, H., Tang, H., Li, X., & Shi, D. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.11.031 · Cited by 26
Goetz, T. G., Mamillapalli, R., Şahin, Ç., Zolbin, M. M., Ge, G., Mani, A., & Taylor, H. S. (2017) · Endocrinology · doi:10.1210/en.2017-00884 · Cited by 27
Zhao, L., Li, J., Yuan, F., Li, M., Zhang, Q., Pang, J., Zhang, B., Sun, F., Sun, H., Li, Q., et al. (2015) · Marine Drugs · doi:10.3390/md13042306 · Cited by 27
State of the art: Atherosclerosis in a limited edition
Rader, D. J., & FitzGerald, G. A. (1998) · Nature Medicine · doi:10.1038/nm0898-899 · Cited by 26
Dietary γ-Linolenic Acid Modulates Macrophage–Vascular Smooth Muscle Cell Interactions
Fan, Y.-Y., Ramos, K. S., & Chapkin, R. S. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1397 · Cited by 26
Murine Mentors: Transgenic and Knockout Models of Surgical Disease
Arbeit, J. M., & Hirose, R. (1999) · Annals of Surgery · doi:10.1097/00000658-199901000-00004 · Cited by 26
Babińska, A., Clement, C. C., Przygodzki, T., Talar, M., Li, Y., Braun, M., Wzorek, J., Świątkowska, M., Ehrlich, Y. H., Kornecki, E., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.02.014 · Cited by 25
Auto-Antibody Production During Experimental Atherosclerosis in ApoE-/- Mice
Hutchinson, M. A., Park, H.-S., Zanotti, K. J., Álvarez, J. A. G., Zhang, J., Zhang, L., Telljohann, R. S., Wang, M., Lakatta, E. G., Gearhart, P. J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.695220 · Cited by 25
Iron metabolism and atherosclerosis
Guo, Q., Qian, C., & Qian, Z. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.04.003 · Cited by 28
Modes of Defining Atherosclerosis in Mouse Models: Relative Merits and Evolving Standards
Daugherty, A., Lu, H. S., Howatt, D. A., & Rateri, D. L. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-247-6_1 · Cited by 25
Intermedin ameliorates atherosclerosis in apoE null mice by modifying lipid profiles
Zhang, X., Gu, L., Chen, X., Wang, S., Deng, X., Liu, K., Lv, Z., Yang, R., He, S., Peng, Y., et al. (2012) · Peptides · doi:10.1016/j.peptides.2012.07.011 · Cited by 25
Nayyar, G., Handattu, S. P., Monroe, C. E., Chaddha, M., Datta, G., Mishra, V., Keenum, T. D., Palgunachari, M. N., Garber, D. W., & Anantharamaiah, G. M. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.09.030 · Cited by 25
Nogueira, B. V., Peotta, V. A., Meyrelles, S. S., & Vasquez, E. C. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.06.005 · Cited by 25
Galloway, S., Pallebage‐Gamarallage, M. M., Takechi, R., Jian, L., Johnsen, R. D., Dhaliwal, S. S., & Mamo, J. C. L. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-15 · Cited by 25
Madsen, M., Hansen, P. R., Nielsen, L. B., Hartvigsen, K., Pedersen, A. E., Christensen, J. P., Aarup, A., & Pedersen, T. X. (2016) · BMC Dermatology · doi:10.1186/s12895-016-0046-1 · Cited by 25
Apolipoprotein A-I Mimetic Peptides
Ditiatkovski, M., Palsson, J., Chin-Dusting, J. P. F., Remaley, A. T., & Sviridov, D. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309523 · Cited by 25
The Role of Age-Related Intimal Remodeling and Stiffening in Atherosclerosis
VanderBurgh, J. A., & Reinhart‐King, C. A. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.08.008 · Cited by 24
Nachtigal, P., Jamborova, G., Pospisilova, N., Pospěchová, K., Solichová, D., Zdansky, P., & Semecký, V. (2006) · PubMed · Cited by 25
Schulz, S., Schagdarsurengin, U., Greiser, P., Birkenmeier, G., Müller‐Werdan, U., Hagemann, M. M., Riemann, D., Werdan, K., & Gläser, C. (2002) · Human Mutation · doi:10.1002/humu.9070 · Cited by 25
Handschug, K., Schulz, S., Schnürer, C., Köhler, S., Wenzel, K., Teichmann, W., & Gläser, C. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050255 · Cited by 25
Huebbe, P., Bilke, S., Rueter, J., Schloesser, A., Campbel, G., Glüer, C.-C., Lucius, R., Röcken, C., Tholey, A., & Rimbach, G. (2024) · Aging and disease · doi:10.14336/ad.2023.0530 · Cited by 24
Adenosine A 3 Receptor: A promising therapeutic target in cardiovascular disease
Nishat, S., Khan, L. A., Ansari, Z. M., & Basir, S. F. (2016) · Current Cardiology Reviews · doi:10.2174/1573403x12666160111125116 · Cited by 24
Immunohistochemical biomarkers and distribution of telocytes in ApoE−/− mice
Xu, Y., Tian, H., Cheng, J., Liang, S., Li, T., & Liu, J. (2019) · Cell Biology International · doi:10.1002/cbin.11128 · Cited by 24
Pathways linking aging and atheroprotection in Mif ‐deficient atherosclerotic mice
Krammer, C., Yang, B., Reichl, S., Besson‐Girard, S., Ji, H., Bolini, V., Schulte, C., Noels, H., Schlepckow, K., Jocher, G., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202200056r · Cited by 26
FoxO4 inhibits atherosclerosis through its function in bone marrow derived cells
Zhu, M., Zhang, Q.-J., Wang, L., Li, H., & Liu, Z.-P. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.09.038 · Cited by 24
Vasquez, E. C., Peotta, V. A., & Meyrelles, S. S. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000277623 · Cited by 24
Choi, D. H., Lee, Y. J., Oh, H. C., Cui, Y., Kim, J. S., Kang, D. G., & Lee, H. S. (2011) · Journal of Medicinal Food · doi:10.1089/jmf.2010.1222 · Cited by 24
Liang, X., Yang, L., Guo, R., Shi, Y.-K., Hou, X., Yang, Z., Zhou, X., & Liu, H. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4062 · Cited by 24
Vilšķe̅rsts, R., Kuka, J., Liepinsh, E., Makrecka‐Kuka, M., Volska, K., Makarova, E., Sevostjanovs, E., Cirule, H., Grı̄nberga, S., & Dambrova, M. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.05.005 · Cited by 24
Selective role of Nck1 in atherogenic inflammation and plaque formation
Alfaidi, M., Acosta, C. H., Wang, D., Traylor, J. G., & Orr, A. W. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135552 · Cited by 24
Ultrasonic tissue characterization of collagen in lipid-rich plaques in apoE-deficient mice
Saijo, Y. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00435-x · Cited by 24
Li, Q., Li, Y., Zhang, Z., Gilbert, T. R., Matsumoto, A. H., Dobrin, S. E., & Shi, W. (2007) · Stroke · doi:10.1161/strokeaha.107.492165 · Cited by 24
Mullick, A. E., Deckelbaum, R. J., Goldberg, I. J., Al-Haideri, M. T., & Rutledge, J. C. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000040221.70377.19 · Cited by 24
Isoform-specific effects of apolipoprotein E on atherogenesis: gene transduction studies in mice
Yoshida, H., Hasty, A. H., Major, A. S., Ishiguro, H., Su, Y. R., Gleaves, L. A., Babaev, V. R., Linton, M. F., & Fazio, S. (2001) · Circulation · doi:10.1161/hc4801.100034 · Cited by 24
Pal, R., Ke, Q., Pihan, G. A., Yesilaltay, A., Penman, M., Wang, L., Chitraju, C., Kang, P. M., Krieger, M., & Kocher, O. N. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00463.2016 · Cited by 23
Apolipoprotein E Deficiency Causes Endothelial Dysfunction in the Mouse Retina
Zadeh, J. K., Zhutdieva, M. B., Laspas, P., Yüksel, C., Musayeva, A., Pfeiffer, N., Brochhausen, C., Oelze, M. W., Daiber, A., Xia, N., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5181429 · Cited by 24
Boléa, G., Philouze, C., Dubois, M., Risdon, S., Humberclaude, A., Giniès, C., Charles, A., Gény, B., Reboul, C., Arnaud, C., et al. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000487 · Cited by 23
Pellico, J., Fernández‐Barahona, I., Ruı́z-Cabello, J., Gutiérrez, L., Muñoz-Hernando, M., Sánchez-Guisado, M. J., Aiestarán-Zelaia, I., Martínez‐Parra, L., Rodríguez, I., Bentzon, J. F., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c13417 · Cited by 23
Gan, G., Lu, B., Zhang, R., Luo, Y., Chen, S., Lei, H., Li, Y., Cai, Z., & Huang, X. (2021) · International Endodontic Journal · doi:10.1111/iej.13655 · Cited by 23
P2X7 receptor-specific radioligand 18F-FTTM for atherosclerotic plaque PET imaging
Fu, Z., Lin, Q., Xu, Z., Zhao, Y., Cheng, Y., Shi, D., Fu, W., Yang, T., Shi, H., & Cheng, D. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05689-w · Cited by 23
May, L. T., Bartolo, B. A. D., Harrison, D. G., Guzik, T. J., Drummond, G. R., Figtree, G. A., Ritchie, R. H., Rye, K., & de Haan, J. B. (2022) · Clinical Science · doi:10.1042/cs20210862 · Cited by 23
Wang, S.-Q., Xiang, J. H., Zhang, G., Fu, L., Xu, Y., Chen, Y., Tao, L., Hu, X., & Shen, X. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155227 · Cited by 23
Novel insights into the development of atherosclerosis in hemophilia A mouse models
Fabri, D. R., Paula, E. V. D., Costa, D. S. P., Annichino‐Bizzacchi, J. M., & Arruda, V. R. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04410.x · Cited by 23
Jeon, U. S., Choi, J., Kim, Y., Sung-Ho, R., & Kim, Y.-K. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.19 · Cited by 23
VPO1 Mediates ApoE Oxidation and Impairs the Clearance of Plasma Lipids
Yang, Y., Cao, Z., Tian, L., Garvey, W. T., & Cheng, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057571 · Cited by 23
Boldt, H. B., Bale, L. K., Resch, Z. T., Oxvig, C., Overgaard, M. T., & Conover, C. A. (2012) · Endocrinology · doi:10.1210/en.2012-1552 · Cited by 23
Why should a doctor be interested in oral disease?
Ford, P. J., Raphael, S. L., Cullinan, M. P., Jenkins, A. J., West, M., & Seymour, G. J. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.109 · Cited by 23
Corticosterone accelerates atherosclerosis in the apolipoprotein E-deficient mouse
Okutsu, M., Lira, V. A., Higashida, K., Peake, J. M., Higuchi, M., & Suzuki, K. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.076 · Cited by 24
Kelly, N. J., Radder, J. E., Baust, J., Burton, C. L., Lai, Y., Potoka, K. C., Agostini, B., Wood, J. P., Bachman, T. N., Vanderpool, R. R., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0176oc · Cited by 23
Busnelli, M., Manzini, S., Bonacina, F., Soldati, S., Barbieri, S. S., Amadio, P., Sandrini, L., Arnaboldi, F., Donetti, E., Laaksonen, R., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14869 · Cited by 23
Modelling of atherosclerosis in genetically modified animals.
Mushenkova, N. V., Summerhill, V. I., Silaeva, Y. Y., Deykin, A. V., & Orekhov, A. N. (2019) · Europe PMC (PubMed Central) · Cited by 23
Farra, Y. M., Matz, J., Ramkhelawon, B., Oakes, J. M., & Bellini, C. M. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00893.2020 · Cited by 23
Variation in Type 2 Diabetes-Related Phenotypes among Apolipoprotein E-Deficient Mouse Strains
Liu, S., Li, J., Chen, M., Liu, Z., & Shi, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120935 · Cited by 23
Rao, L. N., Ponnusamy, T., Philip, S., Mukhopadhyay, R., Kakkar, V. V., & Mundkur, L. (2015) · Lipids · doi:10.1007/s11745-015-4046-4 · Cited by 23
Mao, L., Zhou, Q., Zhou, S., Wilbur, R. R., & Li, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058168 · Cited by 23
Calcium-channel modulators for cardiovascular disease
Godfraind, T. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.1.49 · Cited by 23
Zhou, Y., CHEN, R., Catanzaro, S., Hu, L., Dansky, H. M., & Catanzaro, D. F. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.11.005 · Cited by 23
Liu, G., Hu, Y., Xiao, J., Li, X., Li, Y., Tan, H., Zhao, Y., Cheng, D., & Shi, H. (2016) · Scientific Reports · doi:10.1038/srep20900 · Cited by 23
Villeneuve, N., Fortuño, A., Sauvage, M., Fournier, N., Breugnot, C., Jacquemin, C., Petit, C., Gosgnach, W., Carpentier, N., Vanhoutte, P. M., et al. (2003) · Journal of Vascular Research · doi:10.1159/000070705 · Cited by 23
Pfuetze, K. D., & Dujovne, C. A. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0094-0 · Cited by 23
Ramms, B., Patel, S., Sun, X., Pessentheiner, A. R., Ducasa, G. M., Mullick, A. E., Lee, R. G., Crooke, R. M., Tsimikas, S., Witztum, J. L., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.158414 · Cited by 22
Karunakaran, D., Kockx, M., Owen, D. M., Burnett, J. R., Jessup, W., & Kritharides, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.428961 · Cited by 22
Macrophages, dendritic cells, and regression of atherosclerosis
Feig, J. E., & Feig, J. L. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00286 · Cited by 22
Hypercholesterolemia impairs exercise capacity in mice
Maxwell, A. J., Niebauer, J., Lin, P. S., Tsao, P. S., Bernstein, D., & Cooke, J. P. (2009) · Vascular Medicine · doi:10.1177/1358863x08100040 · Cited by 22
Tanaka, H., 飯田, 泰., Iwaki, T., Suzuki, Y., Sano, H., Miyajima, C., Zaima, N., Sasaki, T., Sumioka, A., Hakamata, S., et al. (2017) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2017.10.006 · Cited by 22
Sun, H., Wang, D., Liu, D., Guo, Z., Shao, C., Sun, W., & Zeng, Y. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-01668-7 · Cited by 21
Cui, Y., Liu, J., Huang, C., & Zhao, B. (2019) · Acupuncture in Medicine · doi:10.1136/acupmed-2016-011317 · Cited by 22
Xie, Q., Xiong, F., Wu, X., Chen, J., Gu, X., Su, C., Xiao, L., Zheng, Z., Wei, Y., Ullah, H., et al. (2019) · Food & Function · doi:10.1039/c9fo02654a · Cited by 22
Yaghoubi, M., Oliver-Krasinski, J. M., Cayatte, A. J., & Cohen, R. A. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200012000-00010 · Cited by 22
Whitman, S. C., & Ramsamy, T. A. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-159 · Cited by 22
Fujii, A., Allen, T. J., & Nestel, P. J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.024 · Cited by 22
Direct Evidence for a Crucial Role of the Arterial Wall in Control of Atherosclerosis Susceptibility
Pei, H., Wang, Y., Miyoshi, T., Zhang, Z., Matsumoto, A. H., Helm, G. A., Tellides, G., & Shi, W. (2006) · Circulation · doi:10.1161/circulationaha.106.640185 · Cited by 22
Zlot, C. H., Flynn, L. M., Véniant, M. M., Kim, E., Raabe, M., McCormick, S. P. A., Ambroziak, P., McEvoy, L. M., & Young, S. G. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33341-1 · Cited by 22
Apolipoprotein E-Deficient Mouse Model of Human Atherosclerosis
O’Neill, T. (1997) · Toxicologic Pathology · doi:10.1177/019262339702500104 · Cited by 21
Fu, X., Zhai, S., & Ji, Y. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.09.023 · Cited by 21
Endometriosis promotes atherosclerosis in a murine model
Mamillapalli, R., Toffoloni, N., Habata, S., Huang, Q., Atwani, R. W., Stachenfeld, N. S., & Taylor, H. S. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.03.040 · Cited by 21
Zhang, Z., Rowlan, J. S., Wang, Q., & Shi, W. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.961649 · Cited by 21
Heinonen, S. E., Merentie, M., Hedman, M., Mäkinen, P. I., Loponen, E., Kholová, I., Bosch, F., Laakso, M., & Ylä‐Herttuala, S. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-59 · Cited by 21
Yuan, Z., Pei, H., Roberts, D. J., Zhang, Z., Rowlan, J. S., Matsumoto, A. H., & Shi, W. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.792499 · Cited by 21
Liu, F., Sahoo, R., Ge, X., Wu, L., Ghosh, P., Qin, X., & Halperin, J. A. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.08.021 · Cited by 21
FoxO transcription factors are required for hepatic HDL cholesterol clearance
Lee, S. X., Heine, M., Schlein, C., Ramakrishnan, R., Liu, J., Belnavis, G., Haimi, I., Fischer, A. W., Ginsberg, H. N., Heeren, J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94230 · Cited by 22
González-Ramos, S., Fernández-García, V., Recalde, M., Rodrı́guez, C., Martínez‐González, J., Andrés, V., Martín‐Sanz, P., & Boscá, L. (2020) · Cells · doi:10.3390/cells9092067 · Cited by 21
Zhou, Y., Wan, X., Seidel, K., Zhang, M., Goodman, J. B., Seta, F., Hamburg, N. M., & Han, J. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020441 · Cited by 21
Abou Ziki, M. D., Strulovici-Barel, Y., Hackett, N. R., Rodriguez-Flores, J. L., Mezey, J. G., Salit, J., Radisch, S., Hollmann, C., Chouchane, L., Malek, J., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.09.021 · Cited by 21
Immunological aspects of atherosclerosis
Garrido‐Urbani, S., Meguenani, M., Montecucco, F., & Imhof, B. A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0402-8 · Cited by 21
Altered Gene Expression in Early Atherosclerosis Is Blocked by Low Level Apolipoprotein E
Ma, Y., Malbon, C. C., Williams, D. L., & Thorngate, F. E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002503 · Cited by 21
Raveendran, V. V., Kassel, K. M., Smith, D. D., Luyendyk, J. P., Williams, K. J., Cherian, R., Reed, G. A., Flynn, C. A., Csanaky, I. L., Lickteig, A. J., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00027.2014 · Cited by 21
Influence of Apolipoprotein E Genotype on Progression of Diabetic Nephropathy
Joss, N., Jardine, A. G., Gaffney, D. F., & Boulton‐Jones, J. M. (2005) · Nephron Experimental Nephrology · doi:10.1159/000087577 · Cited by 21
Lee, K., Forudi, F., Saidel, G. M., & Penn, M. S. (2005) · Circulation Research · doi:10.1161/01.res.0000181026.94390.c9 · Cited by 21
Shi, W., Pei, H., Fischer, J. J., James, J. C., Angle, J. F., Matsumoto, A. H., Helm, G. A., & Sarembock, I. J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400254-jlr200 · Cited by 21
Wolle, S., Via, D. P., Chan, L., Cornicelli, J. A., & Bisgaier, C. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118030 · Cited by 21
Updates on Approaches for Studying Atherosclerosis
Wu, C., Daugherty, A., & Lu, H. S. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312001 · Cited by 21
Pathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
(1996) · PubMed Central · Cited by 32
Metadata
- Authors
- Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R.
- Affiliations
- University of Washington (US)
- Venue
- Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Published
- 1994-01
- Volume
- 14
- Issue
- 1
- Pages
- 133-140
- ISSN
- 1049-8834 (ISSN-L)
- OpenAlex
- W1964814612
- Cited by
- 1,693
- References
- 28
- Citations by year
- 2026: 18 · 2025: 32 · 2024: 40 · 2023: 42 · 2022: 54 · 2021: 60 · 2020: 47 · 2019: 57 · 2018: 45 · 2017: 66 · 2016: 50 · 2015: 69 · 2014: 71 · 2013: 73 · 2012: 78
- FWCI
- 14.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis and Thrombosis A Journal of Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- National Institutes of Health (5r01hl033714-17, 18645, HL 18645)
- National Heart, Lung, and Blood Institute (HL-18645, HL 33714, R01HL032435, HL32435, P01HL018645)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- apolipoprotein E deficiency, atherosclerosis, atherosclerotic plaque development, Western diet, hypercholesterolemia, fibrous cap, necrotic core, aortic root lesions, mouse model of atherosclerosis, atherogenesis
- MeSH terms
- Animals, Aorta, Aorta, Thoracic, Apolipoproteins E, Arteriosclerosis, Carotid Arteries, Coronary Vessels, Diet, Endothelium, Vascular, Hypercholesterolemia, Leukocytes, Mononuclear, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Microscopy, Electron, Pulmonary Artery, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review